4//SEC Filing
Hirmand Mohammad 4
Accession 0001209191-21-009378
CIK 0001595893other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:03 PM ET
Size
7.3 KB
Accession
0001209191-21-009378
Insider Transaction Report
Form 4
Hirmand Mohammad
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2021-02-08+6,483→ 6,767 total - Award
Stock Option (right to buy)
2021-02-08+29,175→ 29,175 totalExercise: $140.01Exp: 2031-02-07→ Common Stock (29,175 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]1/48th of the shares vest monthly following February 8, 2021.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001654482
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 6:03 PM ET
- Size
- 7.3 KB